Page last updated: 2024-08-25

ubenimex and B16 Melanoma

ubenimex has been researched along with B16 Melanoma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's4 (50.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koizumi, K; Minami, T; Saiki, I; Saitoh, Y; Sakurai, H; Sekine, K1
Carmona, AK; Juliano, L; Juliano, MA; Monteiro, HP; Oliveira, V; Paschoalin, T; Rodrigues, EG; Travassos, LR1
Belowski, D; Herman, ZS; Kowalski, J; Madej, A1
Fujimoto, Y; Hashimoto, Y; Kadoya, S; Kagechika, H; Kato, F; Kato, M; Koiso, Y; Komoda, M; Miyata, K; Takayama, H1
Abe, F; Black, PL; Pelus, LM; Talmadge, JE2
Abe, F; Black, PL; Schneider, M; Talmadge, JE1
Abe, F; Alvord, G; Koyama, M; Matsuda, A; Talmadge, JE1

Other Studies

8 other study(ies) available for ubenimex and B16 Melanoma

ArticleYear
A derivative of aminopeptidase inhibitor (BE15) has a dual inhibitory effect of invasion and motility on tumor and endothelial cells.
    Biological & pharmaceutical bulletin, 2006, Volume: 29, Issue:4

    Topics: Aminopeptidases; Animals; Antibiotics, Antineoplastic; Capillaries; Cell Line; Cell Movement; Cell Survival; Endothelial Cells; Extracellular Matrix; Humans; Leucine; Melanoma, Experimental; Mice; Neoplasm Invasiveness; Neoplasms; Protease Inhibitors; Wound Healing

2006
Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.
    Molecular cancer, 2007, Jul-09, Volume: 6

    Topics: Angiogenic Proteins; Animals; Antineoplastic Agents; Bradykinin; Cell Extracts; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cloning, Molecular; Coculture Techniques; Collagen; Culture Media, Conditioned; Dipeptides; Dose-Response Relationship, Drug; Drug Combinations; Endothelial Cells; Female; Hydrolysis; Laminin; Leucine; Melanoma, Experimental; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Neurotensin; Nitric Oxide; Nitric Oxide Donors; Oligopeptides; Peptides; Phenanthrolines; Protease Inhibitors; Proteoglycans; S-Nitroso-N-Acetylpenicillamine; Substrate Specificity

2007
Antitumor activity of bestatin and thiorphan in mice.
    Archivum immunologiae et therapiae experimentalis, 1995, Volume: 43, Issue:5-6

    Topics: Animals; Antineoplastic Agents; Drug Synergism; Female; Killer Cells, Natural; Leucine; Macrophages; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Naloxone; Protease Inhibitors; Thiorphan

1995
Potent homophthalimide-type inhibitors of B16F10/L5 mouse melanoma cell invasion.
    Biological & pharmaceutical bulletin, 1999, Volume: 22, Issue:9

    Topics: Aminopeptidases; Animals; Antineoplastic Agents; Enzyme Inhibitors; Humans; Hydroxamic Acids; Isoquinolines; Leucine; Melanoma, Experimental; Mice; Neoplasm Invasiveness; Tumor Cells, Cultured

1999
Hematopoietic and therapeutic properties of bestatin in normal and myelosuppressed mice.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1991, Volume: 45, Issue:2-3

    Topics: Animals; Antibiotics, Antineoplastic; Bone Marrow Diseases; Cyclophosphamide; Drug Therapy, Combination; Female; Hematopoiesis; Hematopoietic Stem Cells; Leucine; Melanoma, Experimental; Mice; Mice, Inbred C57BL

1991
Hematopoietic and hematologic properties of bestatin in normal and cyclophosphamide myelosuppressed mice.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1990, Volume: 44, Issue:2

    Topics: Aminopeptidases; Animals; Bone Marrow; Cell Count; Cyclophosphamide; Drug Therapy, Combination; Hematopoietic Stem Cells; Immune Tolerance; Leucine; Lung Neoplasms; Melanoma, Experimental; Mice

1990
Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice.
    Cancer immunology, immunotherapy : CII, 1989, Volume: 29, Issue:4

    Topics: Adjuvants, Immunologic; Animals; Combined Modality Therapy; Cyclophosphamide; Cytotoxicity, Immunologic; Immunity, Cellular; Killer Cells, Natural; Leucine; Lymphoma; Macrophages; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental

1989
Pharmacokinetics of bestatin and oral activity for treatment of experimental metastases.
    Cancer immunology, immunotherapy : CII, 1989, Volume: 28, Issue:1

    Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Drug Administration Schedule; Injections, Intravenous; Leucine; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL

1989